Urovant Sciences Ltd. announced earnings results for the second quarter ended September 30, 2020. For the second quarter, the company announced net loss was USD 35.156 million compared to USD 25.741 million a year ago. Basic loss per share from continuing operations was USD 1.12 compared to USD 0.85 a year ago. For the half year, net loss was USD 65.650 million compared to USD 54.226 million a year ago. Basic loss per share from continuing operations was USD 2.12 compared to USD 1.79 a year ago.